• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Sidus Space Appoints Bill White as Chief Financial Officer

    2/8/24 8:30:00 AM ET
    $PRPH
    $SIDU
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Telecommunications Equipment
    Telecommunications
    Get the next $PRPH alert in real time by email

    Sidus Space (NASDAQ:SIDU) (the "Company" or "Sidus"), a multi-faceted Space and Data-as-a-Service company, today announced the appointment of Bill White as Chief Financial Officer, effective February 20, 2024.

    Mr. White will oversee the Company's accounting, financial planning, capital raise, treasury, legal and regulatory functions. Mr. White has more than 30 years of experience in financial management, operations, and business development. He most recently served as Chief Financial Officer of ProPhase Labs, Inc. (NASDAQ:PRPH) and prior to ProPhase he was CFO, treasurer, and secretary of Intellicheck, Inc., a technology company listed on the NasdaqGM. Mr. White has broad domestic and international experience including managing rapid and significant growth, import/export, implementing tough cost management initiatives, exploiting new growth opportunities, mergers and acquisitions, strategic planning, resource allocation, tax compliance and organization development.

    "Bill's deep experience as a public company executive alongside his remarkable proficiency in capital markets and M&A, aligns perfectly with the current stage of Sidus' growth," said Carol Craig, Chief Executive Officer of Sidus.

    "I am honored to serve Sidus at this critical time in its growth and evolution and am excited to work with Carol and the management team to capitalize upon the growth opportunities ahead and deliver long-term value for shareholders," said Bill White, incoming Chief Financial Officer.

    Teresa Burchfield has confirmed her intention to step down as Chief Financial Officer after two years with the Company. Burchfield will remain with the Company, serving in an advisory role, to assist White with the transition.

    Craig added, "I have enjoyed working with Teresa and, during her tenure as chief financial officer at the Company, she has made innumerable and invaluable contributions to its success and growth. On behalf of the Board and the entire Sidus team, I'd like to thank Teresa for her valuable contributions and for laying the groundwork for our continued growth in the public and space sectors."

    About Sidus Space

    Sidus Space (NASDAQ:SIDU) is a Space and Data-as-a-Service satellite company focused on mission-critical hardware manufacturing; multi-disciplinary engineering services; satellite design, production, launch planning, mission operations; and in-orbit support. The Company is located in Cape Canaveral, Florida, where it operates from a 35,000-square-foot manufacturing, assembly, integration, and testing facility focused on vertically integrated Space-as-a-Service solutions including end-to-end satellite support.

    Sidus Space has a mission of Bringing Space Down to Earth™ and a vision of enabling space flight heritage status for new technologies while delivering data and predictive analytics to domestic and global customers. Any corporation, industry, or vertical can start their journey off-planet with Sidus Space's rapidly scalable, low-cost satellite services, space-based solutions, and testing alternatives. More than just a "Satellite-as-a-Service" provider, Sidus Space is a trusted Mission Partner–from concept to Low Earth Orbit and beyond. Sidus Space is ISO 9001:2015, AS9100 Rev. D certified, and ITAR registered.

    Forward-Looking Statements

    Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute ‘forward-looking statements' within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words ‘anticipate,' ‘believe,' ‘continue,' ‘could,' ‘estimate,' ‘expect,' ‘intend,' ‘may,' ‘plan,' ‘potential,' ‘predict,' ‘project,' ‘should,' ‘target,' ‘will,' ‘would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and other factors described more fully in the section entitled ‘Risk Factors' in Sidus Space's Annual Report on Form 10-K for the year ended December 31, 2022, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Sidus Space, Inc. specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240208062368/en/

    Get the next $PRPH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $PRPH
    $SIDU

    CompanyDatePrice TargetRatingAnalyst
    ProPhase Labs Inc.
    $PRPH
    1/14/2022$12.00 → $15.00Buy
    HC Wainwright & Co.
    ProPhase Labs Inc.
    $PRPH
    12/20/2021$12.00Buy
    HC Wainwright & Co.
    ProPhase Labs Inc.
    $PRPH
    10/13/2021Buy → Neutral
    Dawson James
    More analyst ratings

    $PRPH
    $SIDU
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sidus Space Partners with VORAGO Technologies to Advance Radiation-Hardened Compute Capabilities for Scalable Space and Defense Infrastructure

      Sidus Space (NASDAQ:SIDU), an innovative space and defense technology company, today announced a strategic collaboration with VORAGO Technologies to validate and integrate next-generation radiation-hardened microcontroller (MCU) technology through VORAGO's Alpha Customer Program. We believe this partnership positions Sidus at the forefront of resilient space and defense systems, enabling the Company to test and integrate VORAGO's new high-performance MCU, designed for operation in extreme space and defense environments, into future Sidus multi-domain missions. The collaboration supports Sidus' mission to deliver mission-critical solutions, enabling resilient, real-time capabilities across

      6/30/25 10:00:00 AM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

      UNIONDALE, NY, June 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, today announced that it has received an extension of 180 calendar days (the "Extension Notice") from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq (the "Bid Price Requirement"), following the expiration of the initial 180 calendar days period to regain compliance on June 24, 2025. NASDAQ stated that it based its determination to grant the extension based on the Company me

      6/26/25 7:30:00 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Sidus Space Advances $120M Agreement with Lonestar, Selects Atomic-6 as Solar Array Partner for Cislunar Data Satellite Mission

      Sidus Space (NASDAQ:SIDU), (the "Company" or "Sidus"), an innovative space and defense technology provider, today announced the next milestone under its expanded $120 million preliminary agreement with Lonestar Data Holdings Inc. to support the world's first lunar data centers. Atomic-6 has been selected to supply its Light Wing™ solar arrays which are expected to power Sidus' LizzieSat® satellites supporting Lonestar's cislunar data storage constellation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623700280/en/Sidus Space selects ATOMIC-6 as solar array partner for cislunar data satellite mission. As part of its $12

      6/23/25 8:30:00 AM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications

    $PRPH
    $SIDU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HC Wainwright & Co. reiterated coverage on ProPhase Labs with a new price target

      HC Wainwright & Co. reiterated coverage of ProPhase Labs with a rating of Buy and set a new price target of $15.00 from $12.00 previously

      1/14/22 6:36:15 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • HC Wainwright & Co. initiated coverage on ProPhase Labs with a new price target

      HC Wainwright & Co. initiated coverage of ProPhase Labs with a rating of Buy and set a new price target of $12.00

      12/20/21 6:25:15 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • ProPhase downgraded by Dawson James

      Dawson James downgraded ProPhase from Buy to Neutral

      10/13/21 10:48:44 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PRPH
    $SIDU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Shuman Jeffrey S bought $24,689 worth of shares (15,000 units at $1.65) (SEC Form 4)

      4 - Sidus Space Inc. (0001879726) (Issuer)

      6/13/25 4:15:18 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • SEC Form 4 filed by Chief Financial Officer Parekh Adarsh

      4 - Sidus Space Inc. (0001879726) (Issuer)

      5/2/25 6:05:10 AM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • SEC Form 4 filed by Chief Financial Officer Parekh Adarsh

      4 - Sidus Space Inc. (0001879726) (Issuer)

      2/26/25 4:45:09 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications

    $PRPH
    $SIDU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Shuman Jeffrey S bought $24,689 worth of shares (15,000 units at $1.65) (SEC Form 4)

      4 - Sidus Space Inc. (0001879726) (Issuer)

      6/13/25 4:15:18 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications

    $PRPH
    $SIDU
    SEC Filings

    See more
    • SEC Form D filed by ProPhase Labs Inc.

      D - ProPhase Labs, Inc. (0000868278) (Filer)

      7/7/25 9:04:47 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Sidus Space Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Sidus Space Inc. (0001879726) (Filer)

      7/1/25 4:15:33 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • ProPhase Labs Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - ProPhase Labs, Inc. (0000868278) (Filer)

      7/1/25 9:00:30 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PRPH
    $SIDU
    Leadership Updates

    Live Leadership Updates

    See more
    • Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going

      USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 18, 2025 /PRNewswire/ -- USA News Group News Commentary – According to a recent report in Newsweek, more Americans younger than 50 are getting cancer. In fact, the report cites a recent study from the National Institutes of Health (NIH), which found that between 2010 and 2019, more than 2 million Americans aged 15 to 49 were diagnosed with cancer, with early-onset cases rising significantly in 14 different cancer types, including breast, colorectal, and kidney cancers. The dire statistics from the study come at a time where Bloomberg has recently reported on the skyrocketing costs of cancer drugs,

      6/18/25 11:19:00 AM ET
      $CATX
      $CGON
      $GALT
      $ONCY
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports

      GARDEN CITY, NY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and consumer products company, today announced the appointment of Stu Hollenshead as Chief Operating Officer, marking a pivotal step in the company's expansion into consumer-centered health and wellness products. As COO, Hollenshead will focus on accelerating ProPhase Labs' consumer-facing strategy, leveraging his deep expertise in direct-to-consumer growth, subscription models, digital marketing, and audience monetization to position the company as a leader in science-backed health solutions. The Company plans to provide additional updat

      2/18/25 8:00:00 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Sidus Space Appoints Adarsh Parekh as New Chief Financial Officer (CFO) to Spearhead Strategic Financial Initiatives

      Sidus Space (NASDAQ:SIDU), an innovative and agile space mission enabler, today announced the appointment of Adarsh Parekh as its new Chief Financial Officer, effective January 27, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250121637159/en/(Photo: Business Wire) Exceptional Financial Leadership Mr. Parekh brings over two decades of financial expertise marked by: $3 billion in M&A, capital markets and direct investing experience A proven record of scaling organizations in industries including aerospace, medical technology, and agriculture A history of implementing strategies to drive profitability and sustain

      1/21/25 8:30:00 AM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications

    $PRPH
    $SIDU
    Financials

    Live finance-specific insights

    See more
    • ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025

      Highlights Multiple Significant Potential Liquidity Events Anticipated Within the Next Few Months Completes Significant Reductions in Overhead and Expenses BE-Smart Esophageal Cancer Test Study has been Submitted in the Journal of Clinical Gastrointestinal Hepatology Company to hold a virtual conference call Tuesday, May 20, 2025, at 10:00 AM ET GARDEN CITY, NY, May 20, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, today reported its financial and operational results for Q1 ended March 31, 2025, and outlined significant strategic corporate developments. Ted Karkus, CEO of ProP

      5/20/25 8:00:00 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Sidus Space Reports First Quarter 2025 Financial Results and Provides Business Update

      Sidus Space (NASDAQ:SIDU) (the "Company" or "Sidus"), an innovative, agile space mission enabler, today announced its financial results for the first quarter ended March 31, 2025, and provided a business update. The Company is scheduled to host a conference call and webcast today, Thursday, May 15, at 5:00 p.m. ET. "Q1 was a pivotal quarter for Sidus as we launched LizzieSat®-3 (LS-3) and advanced a major technology rollout, laying the foundation for future revenue growth. We remain committed to delivering integrated, AI-driven solutions across space, air, land, and sea and are confident in our long-term trajectory," said Carol Craig, Sidus Chairwoman and CEO. "With growing commercial and

      5/15/25 4:45:00 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025

      GARDEN CITY, NY, May 13, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, announced today that they will be presenting first quarter 2025 financial results on a virtual conference call hosted by Renmark Financial on May 20, 2025, at 10:00 am EDT. Ted Karkus, CEO, looks forward to providing shareholders with an update on several positive activities, including the initiative to sell the Company's wholly owned subsidiary, Nebula Genomics, and the Crown Medical Collections initiative to collect tens of millions of dollars in accounts receivable. A press release detailing these results wi

      5/13/25 8:00:00 AM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $PRPH
    $SIDU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

      SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

      11/14/24 7:31:47 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

      SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

      6/28/24 4:13:44 PM ET
      $SIDU
      Telecommunications Equipment
      Telecommunications
    • SEC Form SC 13D/A filed by ProPhase Labs Inc. (Amendment)

      SC 13D/A - ProPhase Labs, Inc. (0000868278) (Subject)

      3/19/24 4:18:00 PM ET
      $PRPH
      Biotechnology: Pharmaceutical Preparations
      Health Care